Stock OCX ONCOCYTE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News OncoCyte Corporation

Equities

OCX

US68235C2061

Real-time Estimate Cboe BZX
Other stock markets
 03:29:45 2024-04-16 pm EDT 		5-day change 1st Jan Change
2.68 USD +5.93% Intraday chart for OncoCyte Corporation -7.92% +7.18%
01:26am Broadwood Capital, Inc. Engages with OncoCyte Corporation CI
Apr. 12 Sector Update: Health Care Stocks Steady Pre-Bell Friday MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Broadwood Capital, Inc. Engages with OncoCyte Corporation
CI
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
AQ
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
AQ
Sector Update: Health Care Stocks Steady Pre-Bell Friday
MT
Transcript : OncoCyte Corporation, Q4 2023 Earnings Call, Apr 12, 2024
Oncocyte Reports Full Year 2023 Financial Results
AQ
OncoCyte Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
OncoCyte Agrees to $15.8 Million Private Placement of Stock, Warrants
MT
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
AQ
Oncocyte : and Bio-Rad Partner on Global Launch of Transplant Assay - Form 8-K
PU
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
AQ
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay
CI
OncoCyte Corporation announced that it expects to receive $15.8 million in funding
CI
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
AQ
Oncocyte to Present at the Sequire Investor Summit in Puerto Rico
AQ
Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
AQ
Oncocyte Corporation Begins FDA Submissions Process for VitaGraft Transplant Assays
CI
Needham Adjusts Price Target on OncoCyte to $3.60 From $4.25, Maintains Buy Rating
MT
Transcript : OncoCyte Corporation, Q3 2023 Earnings Call, Nov 09, 2023
OncoCyte: Q3 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OCX Stock
  4. News OncoCyte Corporation